Carbogen Amcis names Mark C Griffiths as CEO

Carbogen Amcis names Mark C Griffiths as CEO

2:55 PM, 13th July 2011
Carbogen Amcis names Mark C Griffiths as CEO

 

BUBENDORF, SWITZERLAND: Carbogen Amcis AG has named Mark C Griffiths as the new Chief Executive Officer of the company. In his new role, Griffiths will be responsible for Carbogen Amcis’ Swiss business and will report to Jay Vyas, Managing Director of Dishman Pharmaceuticals and Chemicals Ltd, Carbogen Amcis’ parent company.

Mark C Griffiths has been associated with Carbogen Amcis as Director of Operations and CEO for almost ten years. Most recently, he has been working for the Dishman Group as operations advisor overseeing the design and construction of the group’s large-scale manufacturing facilities for commercial supply of highly potent APIs in Shanghai, China and Ahmedabad, India.

“We are delighted that Mark agreed to join Carbogen Amcis as CEO. Mark’s industrial expertise and proven track record in the pharmaceutical industry make him the ideal executive to lead Carbogen Amcis’ growth,” commented Jay Vyas.

Griffiths has over 28 years of relevant industrial experience within the pharmaceutical and fine chemical industry. Qualified as an engineer, he brings a cross-functional ability to anticipate and optimize technical, operational and management issues.

© WOC News

 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Stamicarbon licenses urea technology to Chinese firm

  Hengang Huahe Coal Chemical will use the license for its urea granulation plant to be built in Heilongjiang Province, China.   SITTA ...

Read more
Algae in city’s Roman Baths could fuel the future

BATH, UNITED KINGDOM: The Roman Baths are currently at the centre of a Department of Biology & Biochemistry study aimed at producing renewable bio ...

Read more
Keyuan Petrochemicals asked to delist its shares by NASDAQ

Interim independent investigation completed. Results favourable: Company accounted for revenue properly. Secured new auditor - GHP Horwath; will be ...

Read more
New research could offer alternative to animals in drug tests

READING, UNITED KINGDOM: Researchers funded by the Biotechnology and Biological Sciences Research Council, at the University of Reading, have develope ...

Read more
SEMI forecast: Chip equipment sales to grow 12 per cent in 2011

  SAN JOSE, US: Worldwide sales of semiconductor manufacturing equipment will reach $44.33 billion in 2011, representing growth of 12.1 per ...

Read more
Hikma enhances API sourcing, buys stake in Chinese firm

LONDON, UNITED KINGDOM: Hikma Pharmaceuticals has acquired an undiscosed minority interest in Hubei Haosun Pharmaceutical, based in China, through the ...

Read more